Concepedia

Robert Popovian

RP

Statistics

Publications

5

Citations

937

H-Index

5

Active since

1998

Affiliations

Pfizer (United States)(Current)

University of Southern California

Winthrop-University Hospital

Science Applications International Corporation (United States)

Robert Popovian is an author at Pfizer (United States) specializing in pharmacy, cost-effectiveness analysis, and medicine.

ORCID

Publications per year

1998–2022

5

Publications

5

The cost of treating community-acquired pneumonia

Michael S. Niederman, Jeffrey S. McCombs, Alan N. Unger et al. · Clinical Therapeutics · 1998 · 534 citations

, , +12

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

Hillel P. Cohen, Donna Beydoun, David Chien et al. · Advances in Therapy · 2016 · 208 citations · Full text

, , +13

Treatment cost of acute exacerbations of chronic bronchitis

Michael S. Niederman, Jeffrey S. McCombs, Alan N. Unger et al. · Clinical Therapeutics · 1999 · 151 citations

, , +14

The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals

Duane Schulthess, Harry P. Bowen, Robert Popovian et al. · Therapeutic Innovation & Regulatory Science · 2022 · 29 citations · Full text

, , +17

Accessibility of adult immunizations in pharmacies compared to physician offices in low-income communities

Robert Popovian, Wayne Winegarden, Esteban Rivera et al. · Journal of the American Pharmacists Association · 2022 · 15 citations · Full text

, , +16

1–5 of 5